Townsquare Capital LLC Co Diagnostics, Inc. Transaction History

Townsquare Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$1.0 - $1.5 $7,900 - $11,850	7,900 Added 65.29%	20,000 $26,000
Q2 2023 Nov 13, 2023	SELL	$1.04 - $1.64 $24,669 - $38,902	-23,721 Reduced 66.22%	12,100 $13,000
Q1 2023 May 11, 2023	SELL	$1.39 - $3.24 $43,652 - $101,752	-31,405 Reduced 46.72%	35,821 $53,000
Q3 2022 Nov 10, 2022	BUY	$2.87 - $7.01 $192,938 - $471,254	67,226 New	67,226 $216,000

4.3M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $35.8M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Townsquare Capital LLC with notifications on news.